Apyx Medical (APYX) Enterprise Value (2010 - 2026)

Apyx Medical (APYX) has reported Enterprise Value for 17 consecutive years, with $161.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 189.45% year-over-year to $161.9 million; the trailing twelve-month figure through Jun 2026 stood at $161.9 million (up 189.45% YoY), and the FY2025 full-year result was $114.8 million, up 308.57% from the prior year.
• Enterprise Value improved to $161.9 million in Q2 2026 per APYX's latest filing, from $123.6 million in the prior quarter.
• Across five years, Enterprise Value topped out at $199.0 million in Q1 2022 and bottomed at $10.0 million in Q1 2024.
• Historically, Enterprise Value has averaged $87.2 million across 5 years, with a median of $77.2 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Enterprise Value sank 91.07% in 2024, then surged 491.46% in 2026.
• Over 5 years, Enterprise Value stood at $71.0 million in 2022, then tumbled by 33.31% to $47.3 million in 2023, then slumped by 40.64% to $28.1 million in 2024, then surged by 308.57% to $114.8 million in 2025, then surged by 41.04% to $161.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $161.9 million, $123.6 million, and $114.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.